MA31237B1 - Utilisation de chitosans pour le traitement de maladies inflammatoires des ongles - Google Patents

Utilisation de chitosans pour le traitement de maladies inflammatoires des ongles

Info

Publication number
MA31237B1
MA31237B1 MA32201A MA32201A MA31237B1 MA 31237 B1 MA31237 B1 MA 31237B1 MA 32201 A MA32201 A MA 32201A MA 32201 A MA32201 A MA 32201A MA 31237 B1 MA31237 B1 MA 31237B1
Authority
MA
Morocco
Prior art keywords
chitosan
nail
chitosans
treatment
inflammatory diseases
Prior art date
Application number
MA32201A
Other languages
Arabic (ar)
English (en)
Inventor
Federico Mailland
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38212471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA31237(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of MA31237B1 publication Critical patent/MA31237B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Des formulations pour ongles à base de chitosan sont utiles pour traiter des maladies inflammatoires des ongles comme le psoriasis, la dermatite atopique et le lichen plan. Le chitosan est normalement sous la forme d'un dérivé d'amino polysaccharide, de préférence hydrosoluble, tel que l'hydroxypropyl chitosan. La formulation peut être présentée sous la forme d'un vernis à ongles, d'une pulvérisation, d'une crème, d'une pommade, un gel, d'une lotion ou d'une mousse; sa teneur en chitosan, en dérivé de chitosan ou en un sel de ceux-ci peut être de 0,1 à 25 % en poids par rapport au poids total de la formulation.
MA32201A 2007-02-14 2009-09-04 Utilisation de chitosans pour le traitement de maladies inflammatoires des ongles MA31237B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07102338A EP1958639A1 (fr) 2007-02-14 2007-02-14 Utilisation de chitosanes dans le traitement de maladies inflammatoires des ongles
PCT/EP2008/051479 WO2008098871A2 (fr) 2007-02-14 2008-02-07 Utilisation de chitosans pour le traitement de maladies inflammatoires des ongles

Publications (1)

Publication Number Publication Date
MA31237B1 true MA31237B1 (fr) 2010-03-01

Family

ID=38212471

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32201A MA31237B1 (fr) 2007-02-14 2009-09-04 Utilisation de chitosans pour le traitement de maladies inflammatoires des ongles

Country Status (30)

Country Link
US (1) US8906881B2 (fr)
EP (3) EP1958639A1 (fr)
JP (3) JP2010518139A (fr)
KR (1) KR101468479B1 (fr)
CN (1) CN101641103B (fr)
AR (1) AR065317A1 (fr)
AU (1) AU2008214695B2 (fr)
BR (1) BRPI0807596A2 (fr)
CA (1) CA2676259C (fr)
CL (1) CL2008000443A1 (fr)
CO (1) CO6210818A2 (fr)
CY (1) CY1113822T1 (fr)
DK (1) DK2117565T3 (fr)
EA (1) EA019539B1 (fr)
EC (1) ECSP099631A (fr)
ES (1) ES2394169T3 (fr)
HR (1) HRP20120915T1 (fr)
IL (1) IL200091A (fr)
MA (1) MA31237B1 (fr)
ME (1) ME00828B (fr)
MX (1) MX2009008514A (fr)
MY (1) MY150502A (fr)
NZ (1) NZ578937A (fr)
PL (1) PL2117565T3 (fr)
PT (1) PT2117565E (fr)
RS (1) RS52620B (fr)
SI (1) SI2117565T1 (fr)
UA (1) UA101151C2 (fr)
WO (1) WO2008098871A2 (fr)
ZA (1) ZA200904975B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2324838A1 (fr) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Compositions comprenant du diméthylsulfoxyde
WO2007033180A1 (fr) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Matieres facilitant l'administration du sulfoxyde de dimethyle (dmso) et de composes du meme type
WO2007033083A2 (fr) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Systèmes d’élimination de diméthylsulfoxyde (dmso), composés connexes ou odeurs associées à cette substance
US10201490B2 (en) * 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
BRPI1006826A2 (pt) * 2009-01-08 2017-08-15 Allergan Inc Composições para melhorar o crescimento de unhas
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EA033767B1 (ru) * 2014-06-10 2019-11-22 Makhbuba Nabi Kyzy Velieva Средство против выпадения волос на основе лекарственных растений
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
KR102511613B1 (ko) * 2019-09-23 2023-03-17 포항공과대학교 산학협력단 키토산을 포함하는 면역억제용 조성물 및 이의 용도

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE378109B (fr) 1972-05-19 1975-08-18 Bofors Ab
DE3541305A1 (de) * 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
JPH08245401A (ja) * 1995-03-14 1996-09-24 Osamu Hatanaka 皮膚保護剤
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US7147854B2 (en) * 1997-06-23 2006-12-12 Yes Biotech Laboratories Ltd. Topical treatment of psoriasis using neutralizing antibodies to interleukin-8
JP4185173B2 (ja) 1997-08-07 2008-11-26 株式会社ノエビア 両親媒性キトサン誘導体及びこれを含有する皮膚外用剤
US6740326B1 (en) * 1998-09-10 2004-05-25 Bioequal Ag Topical nail care compositions
DE19911056B9 (de) * 1999-03-12 2005-09-08 Biotec Asa Kosmetische Zubereitungen und deren Verwendung
JP2001055335A (ja) * 1999-08-18 2001-02-27 Toshio Sato アレルギー性皮膚疾患治療剤
JP2001131030A (ja) * 1999-11-08 2001-05-15 Kureha Chem Ind Co Ltd 発毛促進剤
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
NO20005718A (no) 2000-11-13 2001-06-05 Ethics Cosmeceuticals Ab Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugert vitamin A samt fremgangsmåte for fremstilling og anvendelse av denne
KR20020048534A (ko) 2000-12-18 2002-06-24 안병로 파라핀 왁스를 유효성분으로 하는 피부 맛사지 팩제
SE0100166D0 (sv) 2001-01-22 2001-01-22 Tacton Systems Ab Configuration system
KR100457546B1 (ko) 2001-05-02 2004-11-18 주식회사 바이오프로젠 폴리프럭토오스 또는 그 유도체를 이용한 미소구 및 그제조방법
GB0126923D0 (en) 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
PT1455802E (pt) * 2001-12-14 2008-11-03 Dnp Canada Inc Oligossacáridos de quitosano e suas utilizações
KR100470753B1 (ko) * 2003-01-09 2005-03-10 주식회사 자광 수용성 천연필름과 그의 제조방법
JP2004231604A (ja) 2003-01-31 2004-08-19 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai 担体シートおよび徐放性製剤ならびにそれらの製法
EP1491202A1 (fr) * 2003-06-23 2004-12-29 Polichem S.A. Compositions pour l'application à la surface d'ongles pour les réstructurer
US20050112151A1 (en) 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
RU2258516C1 (ru) * 2004-01-20 2005-08-20 Государственное Образовательное Учреждение "Красноярская Государственная Медицинская Академия Министерства Здравоохранения Российской Федерации" Способ лечения красного плоского лишая
JP2005306746A (ja) 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
JP4804770B2 (ja) * 2005-02-28 2011-11-02 株式会社アリミノ ヘアーコンディショニング剤およびその使用方法
EP1874320A1 (fr) * 2005-04-19 2008-01-09 Galderma S.A. Composition d'une solution de type filmogene, comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
CA2611453C (fr) * 2005-06-14 2015-10-06 Genis Ehf. Compositions de derives chitiniques partiellement desacetyles
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
EP1842545A1 (fr) * 2006-04-04 2007-10-10 Marinomed Biotechnologie GmbH Polymère anti-inflammatoire
DE102006049585A1 (de) * 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Also Published As

Publication number Publication date
AR065317A1 (es) 2009-05-27
HK1132919A1 (en) 2010-03-12
JP2016188252A (ja) 2016-11-04
JP6035292B2 (ja) 2016-11-30
UA101151C2 (ru) 2013-03-11
CY1113822T1 (el) 2016-07-27
ME00828B (fr) 2012-03-20
MX2009008514A (es) 2009-08-20
NZ578937A (en) 2012-05-25
DK2117565T3 (da) 2012-11-19
SI2117565T1 (sl) 2013-01-31
AU2008214695A2 (en) 2009-09-03
MY150502A (en) 2014-01-30
CN101641103B (zh) 2013-05-15
CL2008000443A1 (es) 2008-08-22
EA200901113A1 (ru) 2010-02-26
ECSP099631A (es) 2009-12-28
BRPI0807596A2 (pt) 2014-07-22
US8906881B2 (en) 2014-12-09
KR20090121302A (ko) 2009-11-25
CO6210818A2 (es) 2010-10-20
JP2010518139A (ja) 2010-05-27
ZA200904975B (en) 2010-09-29
JP2014208709A (ja) 2014-11-06
HRP20120915T1 (hr) 2012-12-31
EA019539B1 (ru) 2014-04-30
CN101641103A (zh) 2010-02-03
CA2676259C (fr) 2015-07-14
EP2117565A2 (fr) 2009-11-18
EP1958639A1 (fr) 2008-08-20
WO2008098871A2 (fr) 2008-08-21
RS52620B (sr) 2013-06-28
CA2676259A1 (fr) 2008-08-21
ES2394169T3 (es) 2013-01-23
AU2008214695B2 (en) 2013-10-03
AU2008214695A1 (en) 2008-08-21
IL200091A (en) 2013-05-30
IL200091A0 (en) 2010-04-15
PT2117565E (pt) 2013-01-07
PL2117565T3 (pl) 2013-03-29
EP2117565B1 (fr) 2012-10-17
US20100104670A1 (en) 2010-04-29
KR101468479B1 (ko) 2014-12-05
EP2455086A1 (fr) 2012-05-23
WO2008098871A3 (fr) 2008-10-09

Similar Documents

Publication Publication Date Title
MA31237B1 (fr) Utilisation de chitosans pour le traitement de maladies inflammatoires des ongles
US10792258B2 (en) Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
CN111526864A (zh) 辣木籽的蛋白质提取物的化妆品用途
CN108601797A (zh) 皮肤护理组合物
WO2007122421A3 (fr) Composition et ses utilisations
WO2018185408A1 (fr) Ingredient protecteur de l&#39;equilibre de la flore microbienne cutanee et/ou mucosale
CN112638361B (zh) 用于改善皮肤透明度及暗沉的组合物
EP0648107B1 (fr) Composition pour diminuer la chute des cheveux et/ou stimuler leur repousse
JP6746497B2 (ja) スキンケアのための方法
WO2007082864A3 (fr) Utilisation du chavicol comme antiseptique
MY152878A (en) Novel cosmetic cream composition comprising c12-c20 fatty acid
CN102961300A (zh) 一种中草药植物润肤露及其制备方法
FR3111817B1 (fr) Extrait d’Hibiscus sabdariffa et son utilisation pour améliorer la fonction barrière, et favoriser l’hydratation et la desquamation de la peau
CN101953761A (zh) 一种泡泡剂型润发剂
CN102973451A (zh) 一种芦荟润肤霜及其制备方法
JP2003342179A (ja) 老化防止剤
CN107970197A (zh) 一种低刺激性能温和护肤香皂
CN113827519A (zh) 一种具有美白功效的特殊外观啫喱及其制备方法
FR2723314A1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant un extrait de centaurium erythraea et un extrait de siegesbeckia orientalis
CN101259088A (zh) 白醋沐浴露
CN113440452A (zh) 一种透皮促进肌肤再生的舒缓抗衰组合物及其应用
JP3701532B2 (ja) 痩身用化粧料
EP1888027B1 (fr) Produit medicalise pour usage local a base de materiaux naturels
KR100852203B1 (ko) 다시마 추출물을 포함하는 항진균 조성물
CN109260052A (zh) 一种适用范围更广的洗面奶